The Fever and Antipyretic in Critically Illness Evaluation Study
FACE
FACE
Sponsor study identifier
observational
1,426
2 countries
2
Study Start
September 2009
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
December 2009
Actual (reported)Study Completion
December 2009
Actual (reported)The purpose of this multination multicenter observational study is to determine the impact of fever and antipyretic on outcomes in critically ill patients.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 2009
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 15, 2009
Actual (reported)July 16, 2009
Actual (reported)September 2009
Date type not reportedThis date has not been verified as actual or estimated.
December 2009
Actual (reported)December 2009
Actual (reported)28 days mortality
28days after ICU admission
ICU free days at 28 days
28 days after ICU admission
Hospital free days at 28 days
28 days
Ventilator free days at 28 days
28 days at ICU admission
External cooling;Internal cooling;Non steroid anti inflammatory drugs; Acetaminophen; Steroid
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Adult non-neurological critically ill patients required intensive care for more than 48 hour.
The Japanese Society of Intensive Care Medicine
Bunkyo-ku, Tokyo, 113-0033, Japan
Korean Society of Critical Care Medicine
Songpa-gu, Seoul, 138-736, South Korea
Lee BH, Inui D, Suh GY, Kim JY, Kwon JY, Park J, Tada K, Tanaka K, Ietsugu K, Uehara K, Dote K, Tajimi K, Morita K, Matsuo K, Hoshino K, Hosokawa K, Lee KH, Lee KM, Takatori M, Nishimura M, Sanui M, Ito M, Egi M, Honda N, Okayama N, Shime N, Tsuruta R, Nogami S, Yoon SH, Fujitani S, Koh SO, Takeda S, Saito S, Hong SJ, Yamamoto T, Yokoyama T, Yamaguchi T, Nishiyama T, Igarashi T, Kakihana Y, Koh Y; Fever and Antipyretic in Critically ill patients Evaluation (FACE) Study Group. Association of body temperature and antipyretic treatments with mortality of critically ill patients with and without sepsis: multi-centered prospective observational study. Crit Care. 2012 Feb 28;16(1):R33. doi: 10.1186/cc11211.
Younsuck Koh, M.D. PhD
Korean Society of Critical Care Medicine
Masaji Nishimura, M.D. PhD
Japanese Society of Intensive Care Medicine
Jae Yeol Kim, M.D.
Korean Society of Critical Care Medicine
Gee Young Suh, M.D.
Korean Society of Critical Care Medicine
1,426 participants (actual enrollment reported by the registry).
First Submitted
July 15, 2009
First Posted
July 16, 2009
Study Start
September 2009
Date type not reportedThis date has not been verified as actual or estimated.
The Antipyretic Efficacy of Oral and Intravenous Paracetamol and Intramuscular Diclofenac in Patients Presenting With Fever.
Renal replacement therapy free days at 28 days
28 days at ICU admission
Contact the study team to confirm eligibility.
Moritoki Egi, M.D.
Japanese Society of Intensive Care Medicine
Primary Completion
December 2009
Actual (reported)Study Completion
December 2009
Actual (reported)Last Updated
May 19, 2010
Record last verified: 2009-09
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: